Curis | CRIS - Trade Creditors


Curis reported $4.1M in Trade Creditors for its fiscal quarter ending in June of 2025.





Trade Creditors Change Date
Alaunos Therapeutics USD 843K 34K Sep/2025
Amgen USD 20.89B 1.25B Dec/2025
AstraZeneca USD 25.28B 252M Dec/2025
Bayer EUR 7.08B 700M Dec/2025
Bristol-Myers Squibb USD 4.29B 1.14B Sep/2025
CSL USD 3.17B 290M Dec/2025
Curis USD 4.1M 1.01M Jun/2025
Eli Lilly USD 5.38B 1.12B Dec/2025
Exelixis USD 29.62M 4.27M Dec/2025
Gilead Sciences USD 808M 226M Sep/2025
GlaxoSmithKline GBP 15.38B 294M Dec/2025
Incyte USD 1.63B 1.46B Dec/2025
Merck USD 4.15B 102M Sep/2025
Novartis USD 4.46B 99M Dec/2025
Pfizer USD 5.02B 142M Sep/2025
Roche Holding CHF 5.78B 1.27B Dec/2025
Sanofi EUR 22.93B 927M Dec/2025
Takeda JPY 467.59B 28.61B Dec/2025
TG Therapeutics USD 61.64M 72.38M Sep/2025
Verastem USD 9.89M 2.69M Sep/2025
Xoma USD 2.65M 1.52M Sep/2025